liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Microscopic colitis: Current status, present and future challenges Statements of the European Microscopic Colitis Group
Linköping University, Department of Clinical and Experimental Medicine, Division of Clinical Sciences. Linköping University, Faculty of Health Sciences. Östergötlands Läns Landsting, Heart and Medicine Center, Department of Gastroentorology.
University Hospital, Dresden, Germany.
Örebro University Hospital, Sweden and University of Örebro, Sweden .
Regional Hospital Silkeborg, Denmark .
Show others and affiliations
2012 (English)In: Journal of Crohn's and Colitis, ISSN 1873-9946, EISSN 1876-4479, Vol. 6, no 9, 932-945 p.Article in journal (Refereed) Published
Abstract [en]

Microscopic colitis (MC) is an inflammatory bowel disease presenting with chronic, non-bloody watery diarrhoea and few or no endoscopic abnormalities. The histological examination reveals mainly two subtypes of MC, lymphocytic or collagenous colitis. Despite the fact that the incidence in MC has been rising over the last decades, research has been sparse and our knowledge about MC remains limited. Specialists in the field have initiated the European Microscopic Colitis Group (EMCG) with the primary goal to create awareness on MC. The EMCG is furthermore a forum with the intention to promote clinical and basic research. In this article statements and comments are given that all members of the EMCG have considered being of importance for a better understanding of MC. The paper focuses on the newest updates in epidemiology, symptoms and diagnostic criteria, pathophysiology and highlights some unsolved problems. Moreover, a new treatment algorithm is proposed on the basis of new evidence from well-designed, randomized control trials.

Place, publisher, year, edition, pages
Elsevier , 2012. Vol. 6, no 9, 932-945 p.
Keyword [en]
Microscopic colitis, Collagenous colitis, Lymphocytic colitis, Budesonide
National Category
Medical and Health Sciences
URN: urn:nbn:se:liu:diva-85622DOI: 10.1016/j.crohns.2012.05.014ISI: 000309990400009OAI: diva2:572067

Funding Agencies|Tillots Pharma||Falk Pharma||Tillotts Pharma||Ferring||MSD||Astra-Zeneca||Falk Foundation, Germany||MEDA, Sweden||

Available from: 2012-11-26 Created: 2012-11-26 Last updated: 2015-03-25

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Münch, AndreasHjortswang, HenrikStröm, Magnus
By organisation
Division of Clinical SciencesFaculty of Health SciencesDepartment of GastroentorologyGastroenterology and HepatologyDepartment of Endocrinology and Gastroenterology UHL
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 55 hits
ReferencesLink to record
Permanent link

Direct link